BIOSANTE PHARMACEUTICALS INC 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Dec 2, 2004
Insider Transaction Report
Form 4
SIMES STEPHEN M
DirectorV Chair, Pres. and CEO
Transactions
- Tax Payment
Common Stock
2004-11-30$10.44/sh−16,667$174,003→ 116,879 total - Sale
Common Stock
2004-11-30$10.07/sh−50,000$503,500→ 66,879 total - Exercise/Conversion
Common Stock
2004-11-30$2.90/sh+60,000$174,000→ 133,546 total - Exercise/Conversion
Employee Stock Option (right to buy)
2004-11-30$2.90/sh−60,000$174,000→ 0 totalExercise: $2.90Exp: 2005-04-20→ Common Stock (60,000 underlying)
Holdings
- 100(indirect: By Children)
Common Stock
- 69,491(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares underlying this option have fully vested.